MedTrace Logo

Sudden Cardiac Death - Screening Of Risk Factors

NCT01845909 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 15351

Last updated 2017-06-12

No results posted yet for this study

Summary

The investigators have created a way of quickly collecting information in a large scale young population regarding the presence of some severity indicators that may allow us to classify them into: seemingly "low risk" and possible "elevated risk" for the presence of heart disease. It would have to be a short questionnaire, in order to receive a great adherence but that could simultaneously provide precise information, with an adequate description of symptoms and warning signs, in a way that a triage in the young adult population could be performed in the general young adult population in order to select individuals with an indication for personalized clinical evaluation and possible need of complementary diagnostic means. Based on this premise the investigators have developed a fast-response questionnaire named the Sudden Cardiac Death Screening Of risk factorS (SCD-SOS). This questionnaire has already been tested in a population of approximately 1500 young adults, and some changes have been introduced in order to refine its performance.

To best of the investigators knowledge, there are no large scale European surveys estimating the prevalence of cardiac disease and associated clinical symptoms in a non-selected (non-athlete) population of this age group.

Purpose: To screen a young adult population from central regional of Portugal for heart disease possibly associated to a high risk of Sudden Cardiac Death (SCD).

To determine the national prevalence of clinical symptoms of heart disease and of heart disease with increased risk for SCD in this age group.

To detect young adults in risk of SCD and with an indication for evaluation by a cardiologist, and possible need of:

* medical treatment
* electrophysiologic (EP) study and percutaneous ablation
* an implantable cardiovertor defibrillator
* a pacemaker
* other type of specialized cardiac intervention

Conditions

Interventions

OTHER

ECG and survey screening

Sponsors & Collaborators

  • Unidade Local de Saúde de Coimbra, EPE

    collaborator OTHER

  • Administração Regional de Saúde do Centro

    collaborator OTHER

  • Medtronic

    collaborator INDUSTRY

  • University of Coimbra

    lead OTHER

Principal Investigators

  • Rui Providência, M.D. M.Sc. · Coimbra's Hospital Centre and University; Faculty of Medicine, University of Coimbra, Portugal

Eligibility

Min Age
12 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2013-05-31
Completion
2017-12-31

Countries

  • Portugal

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01845909 on ClinicalTrials.gov